Harm Reduction

Zendo Project: Providing Support During Non-Ordinary States of Consciousness

Zendo Project shares insights on supporting individuals in non-ordinary states of consciousness, offering skills and practical tips for helping during psychedelic or emotional crises.

Valerie Beltran, Steve Bagley, Chelsea Rose

PS2023 Harm Reduction Mental Health Plant Medicine Psilocybin Psychedelic Science Research

The Mycologist & The Doctor: Psilocybin in Nature & Medicine

Paul Stamets and Pamela Kryskow discuss the diverse history and potential of psilocybin mushrooms, highlighting their cultural and medical significance in human evolution and mental health treatment. Kryskow emphasizes the

Pam Kryskow, Paul Stamets

PS2023 Harm Reduction Integration MDMA Psychedelic Assisted Therapy Social and Cultural Therapy Ethics

The Art of Simmering in MDMA-Assisted Therapy

Judith Herman's insights on integrating psychedelic therapy with mindfulness to protect against harm from current systems are discussed in this exploration of trauma and healing.

Bruce Poulter, Marcela Ot’alora

PS2023 Harm Reduction Health Equity Policy and Advocacy Psychedelic Assisted Therapy Research and Science Therapy Ethics

Telemedicine models for supporting psychedelic therapy

Panel explores how telemedicine can enhance psychedelic therapy practice, discussing benefits and risks of virtual care in light of pandemic-induced regulatory changes and improved meeting tech.

Juan Pablo Cappello, Jonathan Sabbagh

PS2023 Business Harm Reduction Policy and Advocacy Public Benefit Research and Science Social Justice

Growing up: The next cycle of venture funding for psychedelic companies

Commercial investment dominates psychedelic sector funding, primarily for drug discovery. Non-commercial projects need financial backing for drug policy reform, public health education, harm reduction, and diversity initiatives. Strategic funding can

Daniel Goldberg, Andrew Chomer, Lindsay Hoover, Sasha Cohen

PS2023 Harm Reduction Health Conditions Integration Psilocybin Psychedelic Assisted Therapy Research and Science

Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations

Clinicians and researchers discuss integrating psilocybin-assisted therapy into serious illness care models, presenting preliminary findings from a pilot study in hospice care for patients with terminal illness.

Yvan Beaussant, Roxanne Sholevar, Lisa Summer, Robin McKenna

PS2023 Harm Reduction Integration LSD Psychedelic Assisted Therapy Psychedelic Science Research and Science

Messages From the Underground and Other Elephants in the Room

Dr. Leo Zeff's LSD experiments in 1961 shaped the underground psychedelic community, leading to the Guild of Guides, which was revealed in a Rolling Stone article, now allowing public discourse.

Adele Getty

PS2023 Harm Reduction Integration Policy and Advocacy Psychedelic Assisted Therapy Research Substance Use Disorder

Psychedelics, addiction, and recovery

Psychedelic-assisted therapy's history, Bill W's admiration, and the need for peer support group understanding are discussed in relation to sobriety, recovery, and psychedelics.

Kevin Franciotti, Reilly Capps, Celeste Alvarez, Danielle Nova, Rick Barnett, Juliana Mulligan

PS2023 Depression Harm Reduction Ketamine Mental Health Psychedelic Assisted Therapy Research and Science

Panel discussion: The state of ketamine-assisted therapy

Ketamine, a WHO essential medicine, has long been used globally as an anesthetic. Its off-label use for depression is growing, sparking discussions on efficacy, safety, and regulation.

Raquel Bennet, Sunny Strasburg, Gita Vaid, Danielle M Herrera, Lauren Taus

PS2023 Harm Reduction Health Conditions Ketamine Psychedelic Assisted Therapy Research and Science Therapy Ethics

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses

KAP program offers innovative treatment for adolescents with emotional issues, focusing on family involvement. Successes and challenges of this unique approach are discussed.

Phil Wolfson